Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$42.28 - $51.43 $507 - $617
12 Added 38.71%
43 $2,000
Q1 2023

Apr 18, 2023

SELL
$40.84 - $58.14 $1,633 - $2,325
-40 Reduced 56.34%
31 $1,000
Q4 2022

Feb 07, 2023

SELL
$43.88 - $56.16 $1,711 - $2,190
-39 Reduced 35.45%
71 $7,000
Q3 2022

Nov 08, 2022

BUY
$48.37 - $66.5 $870 - $1,197
18 Added 19.57%
110 $26,000
Q2 2022

Sep 06, 2022

BUY
$57.25 - $86.63 $5,267 - $7,969
92 New
92 $24,000
Q2 2022

Aug 12, 2022

SELL
$57.25 - $86.63 $5,267 - $7,969
-92 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$71.02 - $86.99 $2,698 - $3,305
38 Added 70.37%
92 $7,000
Q1 2022

Aug 08, 2022

BUY
$71.02 - $86.99 $1,633 - $2,000
23 Added 74.19%
54 $4,000
Q1 2021

Apr 30, 2021

SELL
$62.9 - $82.41 $45,036 - $59,005
-716 Reduced 95.85%
31 $2,000
Q4 2020

Jan 25, 2021

SELL
$46.01 - $68.74 $690 - $1,031
-15 Reduced 1.97%
747 $51,000
Q2 2020

Aug 05, 2020

SELL
$39.87 - $56.9 $239 - $341
-6 Reduced 0.78%
762 $35,000
Q1 2020

May 12, 2020

BUY
$34.22 - $76.49 $4,482 - $10,020
131 Added 20.57%
768 $34,000
Q4 2019

Jan 17, 2020

BUY
$68.92 - $85.27 $43,212 - $53,464
627 Added 6270.0%
637 $48,000
Q3 2019

Nov 07, 2019

BUY
$71.74 - $86.35 $502 - $604
7 Added 233.33%
10 $1,000
Q2 2018

Aug 07, 2018

SELL
$81.75 - $105.37 $36,297 - $46,784
-444 Reduced 99.33%
3 $0
Q1 2018

Jun 03, 2019

BUY
$79.95 - $89.74 $35,497 - $39,844
444 Added 14800.0%
447 $36,000
Q1 2018

May 09, 2018

SELL
$79.95 - $89.74 $35,497 - $39,844
-444 Reduced 99.33%
3 $0
Q4 2017

Jan 24, 2018

BUY
$71.8 - $88.21 $21,611 - $26,551
301 Added 206.16%
447 $0
Q2 2017

Jun 03, 2019

BUY
N/A
140 Added 2333.33%
146 $9,000
Q2 2016

Jun 03, 2019

BUY
N/A
3 Added 100.0%
6 $0
Q1 2016

Jun 03, 2019

BUY
N/A
3
3 $0

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.52B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.